Sanofi Pasteur to co-develop E Coli vaccine
This article was originally published in Scrip
Executive Summary
Sanofi Pasteur is to co-develop a preclinical bacterial vaccine against enterotoxigenic Escherichia coli (ETEC) with the US Naval Medical Research Center (NMRC).